We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Mountain Valley MD Holdings Inc (MVMD) NPV

Sell:0.15 CAD Buy:0.16 CAD Change: 0.01 CAD (6.06%)
Market closed |  Prices as at close on 26 November 2021 | Switch to live prices |
Sell:0.15 CAD
Buy:0.16 CAD
Change: 0.01 CAD (6.06%)
Market closed |  Prices as at close on 26 November 2021 | Switch to live prices |
Sell:0.15 CAD
Buy:0.16 CAD
Change: 0.01 CAD (6.06%)
Market closed |  Prices as at close on 26 November 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Mountain Valley MD Holdings Inc. is a Canada-based company. Through its subsidiary, Mountain Valley MD Inc., the Company is engaged in implementing and licensing of its technologies to global pharmaceutical, vaccine and nutraceutical third parties. Its technology include Quicksome oral drug formulation and delivery technologies. The Company’s Quicksome desiccation technology utilizes advanced liposomes and other stabilizing molecules to encapsulate and formulate active ingredients into product formats that are consumed orally. It is also developing other technologies, including Quicksol solubility formulation technology, and pending dose sparing adjuvant.

Contact details

Address:
260 Edgeley Blvd., Unit 4
VAUGHAN
L6K 3Y4
Canada
Telephone:
+1 (604) 6414450
Website:
https://www.mountainvalleymd.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
MVMD
ISIN:
CA62430M1014
Market cap:
50.86 million CAD
Shares in issue:
379.28 million
Sector:
Gold
Exchange:
-
Country:
Canada
Currency:
Canadian dollars
Indices:
n/a

Key personnel

  • Dennis Hancock
    Chairman of the Board, President, Chief Executive Officer
  • Aaron Triplett
    Chief Financial Officer
  • Azhar Rana
    Chief Medical Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.